insulin glargine/lixisenatide (Suliqua®) is accepted for restricted use within NHSScotland

It has been approved for use in combination with metformin for treatment of adults with type 2 diabetes mellitus, who are uncontrolled on basal insulin (HbA1c > 7.5% [59mmol/mol]) and for whom a GLP-1 receptor agonist is appropriate as an add-on therapy to basal insulin analogues


Scottish Medicines Consortium